Lipitor patent expires, saving health insurers on cholesterol drugs

Lipitor patent expires, saving health insurers on cholesterol drugs
Get Business Mobile Text Alerts As the patent expired Wednesday on Pfizer’s cholesterol-lowering drug Lipitor, the marketplace opened to competition by generic substitutes that will save money for patients and health insurers alike.